SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,685.06 |
| Enterprise Value ($M) | 6,149.58 |
| Book Value ($M) | -1,218.39 |
| Book Value / Share | -6.45 |
| Price / Book | -3.85 |
| NCAV ($M) | -1,438.79 |
| NCAV / Share | -7.61 |
| Price / NCAV | -3.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.85 |
| Return on Assets (ROA) | -0.67 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.62 |
| Current Ratio | 3.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 444.58 |
| Assets | 664.98 |
| Liabilities | 1,883.37 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 6.80 | 0.00 | |
| 13D/A | Viking Global Investors Lp | 13.40 | 0.00 | |
| 13D/A | KKR Genetic Disorder L.P. | 13.40 | -18.67 | |
| 13G/A | Kumar Neil | 5.59 | 1.38 | |
| 13G/A | Vanguard Group Inc | 7.36 | 20.85 | |
| 13G/A | BlackRock Inc. | 5.80 | 3.28 | |
| 13G/A | State Street Corp | 2.92 | -42.49 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 447,844 | 1,570,695 | 28.51 | |
| 423,697 | 1,620,181 | 26.15 | |
| 322,239 | 1,954,226 | 16.49 | |
| 281,770 | 1,551,996 | 18.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATRA – Atara Biotherapeutics, Inc. | AVIR – Atea Pharmaceuticals, Inc. |
| AVXL – Anavex Life Sciences Corp. | BCRX – BioCryst Pharmaceuticals, Inc. |
| BDTX – Black Diamond Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io